Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir [Levemir] and Insulin Glargine [Lantus].
Phase of Trial: Phase III
Latest Information Update: 23 May 2013
At a glance
- Drugs Insulin detemir (Primary) ; Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 31 Oct 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 20 Jan 2011 Planned end date changed from 1 Nov 2010 to 1 Oct 2010 as reported by ClinicalTrials.gov.
- 29 Jan 2010 Planned end date changed from 1 Oct 2009 to 1 Nov 2010 as reported by ClinicalTrials.gov.